Fixed ceiling, retail prices to ensure affordable cancer drugs: Govt in LS
In response to a parliamentary query, the ministry said that the Department of Pharmaceuticals, through the National ...
Yen on MSN19m
Trump's trade tempest: Week one
US President Donald Trump's turbulent trade tussle with rivals and allies triggered tit-for-tat moves, more tariff threats ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...
Global HIV Care Thrown Into Chaos by Trump: “I Will Be Sick and Maybe Die”
In South Africa, a 36-year-old living with HIV since childhood fears she will lose access to treatment due to Trump’s policy.
Wells Fargo sets $91 target on Merus stock, cites mCRC potential
Wells Fargo (NYSE:WFC) initiated coverage on Merus N.V. (NASDAQ:MRUS), currently trading at $41.54 with a market capitalization of $2.84 billion, with an Overweight rating and a price target of $91.00 ...